In a milestone year for Brazilian orthopedics, Diffucap celebrates its 50-year history as the Brazilian Society of Orthopedics and Traumatology (SBOT) marks 90 years of activity. This meeting of consolidated trajectories gained even more relevance during the 57th Brazilian Congress of Orthopedics and Traumatology (CBOT), an event that brought together specialists, researchers, and leading companies in the sector.
A Strong Presence at the Congress
Diffucap participated in the CBOT with a robust presence, presenting its new packaging identity to the audience—reflecting modernity, safety, and a strong commitment to quality. The updated visual design reinforces the brand’s positioning and highlights its ongoing concern with providing confidence and a better experience for healthcare professionals.
The company also showcased important innovations in its product portfolio, reaffirming its active role in developing pharmaceutical solutions aimed at both clinical and surgical orthopedics.
Launch of Artrodiff Plus
Among the most anticipated highlights was the launch of Artrodiff Plus, a new formulation developed to complement orthopedic care. The product features advanced technology and a proposal focused on improving joint health, reinforcing Diffucap’s commitment to research, efficacy, and innovation.
The launch reflects the company’s ongoing partnership with specialists in the field, resulting in products that respond to the real needs of patients and healthcare professionals.
Science That Transforms, Movement That Inspires
Participation in the 57th CBOT symbolizes the union of science, experience, and evolution. As Diffucap celebrates five decades of history, it reinforces its mission to actively contribute to musculoskeletal health, aligning with SBOT’s tradition and with the advancement of orthopedics in Brazil.
With innovation, knowledge, and responsibility, the company continues inspiring movement and supporting the transformation of orthopedic practice nationwide.
